Trial Profile
Etoricoxib and indometacin to treat acute gouty arthritis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Apr 2015
Price :
$35
*
At a glance
- Drugs Etoricoxib (Primary) ; Indometacin (Primary)
- Indications Gout; Gouty arthritis
- Focus Therapeutic Use
- Sponsors Merck & Co
- 25 Apr 2015 New trial record